Skip to main content
AAN.com

Abstract

Objective: We evaluated the effect of performance feedback on acute ischemic stroke care quality in Minnesota hospitals.
Methods: A cluster-randomized controlled trial design with hospital as the unit of randomization was used. Care quality was defined as adherence to 10 performance measures grouped into acute, in-hospital, and discharge care. Following preintervention data collection, all hospitals received a report on baseline care quality. Additionally, in experimental hospitals, clinical opinion leaders delivered customized feedback to care providers and study personnel worked with hospital administrators to implement changes targeting identified barriers to stroke care. Multilevel models examined experimental vs control, preintervention and postintervention performance changes and secular trends in performance.
Results: Nineteen hospitals were randomized with a total of 1,211 acute ischemic stroke cases preintervention and 1,094 cases postintervention. Secular trends were significant with improvement in both experimental and control hospitals for acute (odds ratio = 2.7, p = 0.007) and in-hospital (odds ratio = 1.5, p < 0.0001) care but not discharge care. There was no significant intervention effect for acute, in-hospital, or discharge care.
Conclusion: There was no definite intervention effect: both experimental and control hospitals showed significant secular trends with performance improvement. Our results illustrate the potential fallacy of using historical controls for evaluating quality improvement interventions.
Classification of evidence: This study provides Class II evidence that informing hospital leaders of compliance with ischemic stroke quality indicators followed by a structured quality improvement intervention did not significantly improve compliance more than informing hospital leaders of compliance with stroke quality indicators without a quality improvement intervention.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (appendix_e-1_questionnaire.pdf)
File (table_e-1.doc)
File (table_e-2.doc)
File (table_e-3.doc)

REFERENCES

1.
Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 2008;39:924–928.
2.
Holloway RG, Benesch C, Rush SR. Stroke prevention: narrowing the evidence-practice gap. Neurology 2000;54:1899–1906.
3.
Holloway RG, Vickrey BG, Benesch C, Hinchey JA, Bieber J, National Expert Stroke Panel. Development of performance measures for acute ischemic stroke. Stroke 2001;32:2058–2074.
4.
Kernan WN, Viscoli CM, Brass LM, Makuch RW, Sarrel PM, Horwitz RI. Blood pressure exceeding national guidelines among women after stroke. Stroke 2000;31:415–419.
5.
Reeves MJ, Arora S, Broderick JP, et al. Acute stroke care in the US: Results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 2005;36:1232–1240.
6.
Lakshminarayan K, Solid CA, Collins AJ, Anderson DC, Herzog CA. Atrial fibrillation and stroke in the general Medicare population: a 10-year perspective (1992 to 2002). Stroke 2006;37:1969–1974.
7.
Soumerai SB, McLaughlin TJ, Gurwitz JH, et al. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA 1998;279:1358–1363.
8.
Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med 1993;329:1271–1273.
9.
Zimmerman JE, Shortell SM, Rousseau DM, et al. Improving intensive care: observations based on organizational case studies in nine intensive care units: a prospective, multicenter study. Crit Care Med 1993;21:1443–1451.
10.
Doumit G, Gattellari M, Grimshaw J, O'Brien MA. Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2007;(1):CD000125.
11.
Shojania KG, Grimshaw JM. Evidence-based quality improvement: the state of the science. Health Aff 2005;24:138–150.
12.
Borbas C, McLaughlin DB, Schultz A. The Minnesota Clinical Comparison and Assessment Program: bridging the gap between clinical practice guidelines and patient care. In: Zablocki E, ed. Changing Physician Practice Patterns: Strategies for Success in a Capitated World. Gaithersburg, MD: Aspen Publishers Inc.; 1995:29.
13.
Hiss RG, MacDonald R, David WR. Identification of physician educational influentials in small community hospitals. Res Med Educ 1978;17:283–288.
14.
Ukoumunne OC, Thompson SG. Analysis of cluster randomized trials with repeated cross-sectional binary measurements. Stat Med 2001;20:417–433.
15.
Murray DM. Design and Analysis of Group-Randomized Trials. New York: Oxford University Press; 1998.
16.
Morgenstern LB, Bartholomew LK, Grotta JC, Staub L, King M, Chan W. Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch Intern Med 2003;163:2198–2202.
17.
Schwamm LH, Fonarow GC, Reeves MJ, et al. Get With The Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation 2009;119:107–115.
18.
Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers: Brain Attack Coalition. JAMA 2000;283:3102–3109.
19.
JCAHO. Primary Stroke Center Certifications. Available at: http://www.jointcommission.org/CertificationPrograms/PrimaryStrokeCenters/. Accessed June 25, 2009.
20.
Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol 2004;57:785–794.
21.
Redfern J, McKevitt C, Wolfe CD. Development of complex interventions in stroke care: a systematic review. Stroke 2006;37:2410–2419.
22.
Berwick DM. The science of improvement. JAMA 2008;299:1182–1184.
23.
Pawson R, Tilley N. Realistic Evaluation. London: Sage Publications Ltd.; 1997.
24.
Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655–1711.
25.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.
26.
CAST (Chinese Acute Stroke Trial) collaborative group. CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997;349:1641–1649.
27.
International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997;349:1569–1581.
28.
Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;289:2560–2572.
29.
Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577–617.
30.
PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033–1041.
31.
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633–638.
32.
Antiplatelet Trialists' collaboration. Collaborative overview of randomised trials of antiplatelet therapy: I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81–106.

Information & Authors

Information

Published In

Neurology®
Volume 74Number 20May 18, 2010
Pages: 1634-1642
PubMed: 20479363

Publication History

Published online: May 17, 2010
Published in print: May 18, 2010

Permissions

Request permissions for this article.

Notes

Authors

Affiliations & Disclosures

K. Lakshminarayan, MD, PhD
From the Department of Neurology, School of Medicine (K.L., G.V., D.C.A.), and Division of Epidemiology and Community Health, School of Public Health (K.L., R.V.L.), University of Minnesota, Minneapolis; and Healthcare Evaluation and Research Foundation (B.M., N.M., C.B.), St. Paul, MN.
C. Borbas, PhD, MPH
From the Department of Neurology, School of Medicine (K.L., G.V., D.C.A.), and Division of Epidemiology and Community Health, School of Public Health (K.L., R.V.L.), University of Minnesota, Minneapolis; and Healthcare Evaluation and Research Foundation (B.M., N.M., C.B.), St. Paul, MN.
B. McLaughlin, RN, BAN, CPHQ
From the Department of Neurology, School of Medicine (K.L., G.V., D.C.A.), and Division of Epidemiology and Community Health, School of Public Health (K.L., R.V.L.), University of Minnesota, Minneapolis; and Healthcare Evaluation and Research Foundation (B.M., N.M., C.B.), St. Paul, MN.
N.E. Morris, MA
From the Department of Neurology, School of Medicine (K.L., G.V., D.C.A.), and Division of Epidemiology and Community Health, School of Public Health (K.L., R.V.L.), University of Minnesota, Minneapolis; and Healthcare Evaluation and Research Foundation (B.M., N.M., C.B.), St. Paul, MN.
G. Vazquez, PhD
From the Department of Neurology, School of Medicine (K.L., G.V., D.C.A.), and Division of Epidemiology and Community Health, School of Public Health (K.L., R.V.L.), University of Minnesota, Minneapolis; and Healthcare Evaluation and Research Foundation (B.M., N.M., C.B.), St. Paul, MN.
R.V. Luepker, MD, MS
From the Department of Neurology, School of Medicine (K.L., G.V., D.C.A.), and Division of Epidemiology and Community Health, School of Public Health (K.L., R.V.L.), University of Minnesota, Minneapolis; and Healthcare Evaluation and Research Foundation (B.M., N.M., C.B.), St. Paul, MN.
D.C. Anderson, MD
From the Department of Neurology, School of Medicine (K.L., G.V., D.C.A.), and Division of Epidemiology and Community Health, School of Public Health (K.L., R.V.L.), University of Minnesota, Minneapolis; and Healthcare Evaluation and Research Foundation (B.M., N.M., C.B.), St. Paul, MN.

Notes

Address correspondence and reprint requests to Dr. K. Lakshminarayan, Department of Neurology, MMC 295, 420 Delaware Street SE, Minneapolis, MN 55455 [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Exploring the content and delivery of feedback facilitation co-interventions: a systematic review, Implementation Science, 19, 1, (2024).https://doi.org/10.1186/s13012-024-01365-9
    Crossref
  2. Identifying behaviour change techniques in 287 randomized controlled trials of audit and feedback interventions targeting practice change among healthcare professionals, Implementation Science, 18, 1, (2023).https://doi.org/10.1186/s13012-023-01318-8
    Crossref
  3. Determining the sample size for a cluster-randomised trial using knowledge elicitation: Bayesian hierarchical modelling of the intracluster correlation coefficient, Clinical Trials, 20, 3, (293-306), (2023).https://doi.org/10.1177/17407745231164569
    Crossref
  4. Towards an Implementation‐STakeholder Engagement Model (I‐STEM) for improving health and social care services, Health Expectations, 26, 5, (1997-2012), (2023).https://doi.org/10.1111/hex.13808
    Crossref
  5. Interventions for the uptake of evidence-based recommendations in acute stroke settings, Cochrane Database of Systematic Reviews, 2023, 8, (2023).https://doi.org/10.1002/14651858.CD012520.pub2
    Crossref
  6. Smartphone-Based Telestroke Vs“Stroke Physician” led Acute Stroke Management (SMART INDIA), Annals of Indian Academy of Neurology, 25, 3, (422-427), (2022).https://doi.org/10.4103/aian.aian_1052_21
    Crossref
  7. Social norms interventions to change clinical behaviour in health workers: a systematic review and meta-analysis, Health Services and Delivery Research, 8, 41, (1-138), (2020).https://doi.org/10.3310/hsdr08410
    Crossref
  8. Moving stroke rehabilitation evidence into practice: a systematic review of randomized controlled trials, Clinical Rehabilitation, 33, 10, (1586-1595), (2019).https://doi.org/10.1177/0269215519847253
    Crossref
  9. Local opinion leaders: effects on professional practice and healthcare outcomes, Cochrane Database of Systematic Reviews, 2019, 6, (2019).https://doi.org/10.1002/14651858.CD000125.pub5
    Crossref
  10. Effect of a Quality Improvement Intervention on Adherence to Therapies for Patients With Acute Ischemic Stroke and Transient Ischemic Attack, JAMA Neurology, 76, 8, (932), (2019).https://doi.org/10.1001/jamaneurol.2019.1012
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share